Researchers from Circle Pharma Inc. have presented preclinical data for CID-078, a novel orally bioavailable cyclin A/B Rxl macrocycle being developed for the treatment of patients with lung cancer.

The CFPB recently denied a lender’s request to set aside or modify a civil investigative demand (CID) issued in January related to its short-term and small-dollar lending practices. The lender’s ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Circle Pharma, a clinical-stage biopharmaceutical company advancing macrocycle therapeutics for difficult-to-treat cancers, today announced that the U.S.

Not long after, Shinra cuts funding to the space program, and Cid's dreams are dashed. As time goes on, and his dream becomes ...

Making small talk with someone you’ve just met can be terrifying. Common sense tells us we need to convince the other person that we’re smart, so we casually drop our job title, education and ...

When you get right down to it, there is really nothing wrong with a late-model Firebird or Camaro that an infusion of horsepower won't cure. GM engineers hit a home run with the styling and handling ...